Application Number Funding Recommendation Title Score DR3-06924 Recommended---- Therapeutic Eradication of Cancer Stem Cells 79 DR3-06965 Recommended---- Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors 79 DR3-07438 Recommended---- Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration 76 DR3-07067 Recommended---- A Phase I dose escalation and expansion clinical trial in patients with advanced solid tumors 76 DR3-07281 Recommended if funds allow---- Tissue Engineered Recellularized Laryngotracheal Implants 70 DR3-07061 Recommended if funds allow---- Subretinal delivery of human neural progenitor cells for the treatment of retinitis pigmentosa 69 DR3-06945 Recommended if funds allow---- Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease 69 DR3-07078 Recommended if funds allow---- Embryonic Stem Cell-Derived Chondroprogenitor Cells to Repair Osteochondral Defects 67 DR3-06929 Not recommended---- Allogeneic Glial Restricted Progenitor Cell Transplantation for Neuroprotection of Motor Neurons in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) 63 DR3-07123 Not recommended---- A Wnt-based therapy targeting endogenous stem cells to enhance skeletal healing in the elderly -- DR3-07000 Not recommended---- Harnessing Native Fat-Residing Stem Cells For Spine Fusion: From Early Translation To Disease Team -- DR3-07307 Not recommended---- Autologous Stem Cell Transplantation with Purified, anti HIV Gene Modified Stem Cells For Treatment of HIV Related Malignancies. -- DR3-07201 Not recommended---- DYNAMIC (Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells) Trial: A randomized, double-blind, placebo-controlled Phase 1a/b multicenter study of allogeneic human cardiosphere-derived cells in patients with advanced heart --